Pharmacy

AvevoRx Closes on Acquisition of Sunrise Rx, Expanding Specialty Infusion Pharmacy Presence Across the Northeast

AvevoRx, a national, independent provider of specialty infusion pharmacy services, announces that it has closed on the acquisition of Sunrise Rx, a fast-growing specialty infusion pharmacy based on Long Island, New York, significantly expanding the company’s operational presence across the Northeast healthcare market. Founded by infusion industry veterans Rich Collins and Dan Manchise, Sunrise Rx […]

AvevoRx Closes on Acquisition of Sunrise Rx, Expanding Specialty Infusion Pharmacy Presence Across the Northeast Read More »

Soleo Health Acquires Realo Specialty Care Pharmacy and BluHaven Management, Expanding Footprint in Mid-Atlantic Region

Soleo Health, an independent specialty pharmacy and infusion therapy provider, announces the Company acquired Realo Specialty Care Pharmacy (“Realo Specialty Care”) and BluHaven Management (“BluHaven”), from parent company Realo Drugs. The acquisition expands Soleo Health’s growing footprint in the Mid-Atlantic region, primarily in North Carolina, South Carolina, Virginia, and Maryland. Realo Specialty Care’s specialty pharmacy,

Soleo Health Acquires Realo Specialty Care Pharmacy and BluHaven Management, Expanding Footprint in Mid-Atlantic Region Read More »

The 340B Contract Pharmacy Market in 2026: A Maturing Industry Dominated by Big Chains and PBMs

Drug Channels Institute (DCI) has published its latest exclusive analysis of the 340B contract pharmacy market, which continues to boom along with the overall program’s expansion. However, the 2026 analysis finds that the contract pharmacy market is now entering a more mature phase characterized by consolidation, slower growth, and increasing dominance by the industry’s largest

The 340B Contract Pharmacy Market in 2026: A Maturing Industry Dominated by Big Chains and PBMs Read More »

WindRose Health Investors Completes Sale of Altruix to Frazier Healthcare Partners

WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that it has completed the sale of Altruix (“Altruix” or the “Company”) to Frazier Healthcare Partners (“Frazier”). Headquartered in Hunt Valley, Maryland, Altruix is a leading behavioral health pharmacy platform serving patients with severe mental illness, substance use disorders, and intellectual and

WindRose Health Investors Completes Sale of Altruix to Frazier Healthcare Partners Read More »

Pharmacy M&A in Transition: Key Trends Shaping 2026

The pharmacy services sector saw substantial M&A activity between June 2025 and May 2026, as private equity firms continued to drive consolidation across specialty pharmacy, infusion services, compounding, and pharma services platforms. This activity reflects a strategic shift toward scale, efficiency, and specialization as organizations respond to rising drug costs and evolving U.S. care models.

Pharmacy M&A in Transition: Key Trends Shaping 2026 Read More »

Frazier Preempts Auction for WindRose-Backed Altruix

Frazier Healthcare Partners preempted a sale process for WindRose Health-backed behavioral health specialty pharmacy Altruix, Axios Pro has learned. Sponsors say specialty pharmacy provides an opportunity to capitalize on growing drug spend and margin, without having to manage the risk and overhead of drug development and manufacturing. Read the full article: Frazier Preempts Auction for

Frazier Preempts Auction for WindRose-Backed Altruix Read More »

Scroll to Top